Tibud, Lolly S.
HRN: 06-47-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/11/2024
02/19/2024
IV
300mg
QID
Pressure Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes